Home › Department of Health and Human Services › Contract 75A50325F80013
ALVOGEN, INC.
Federal contract 75A50325F80013 with Department of Health and Human Services, currently held by ALVOGEN, INC..
Expires 2027-06-29 · in 10 months
- Incumbent
- ALVOGEN, INC.
- Awarding agency
- Department of Health and Human Services
- Sub-agency
- Office of Assistant Secretary for Preparedness and Response
- Industry (NAICS)
- 325412 - Pharmaceutical Preparation Manufacturing
- Ceiling value
- $227,679,090
- Period of performance
- 2025-06-30 to 2027-06-29
- Award ID
- 75A50325F80013
Contract description
OSELTAMIVIR PHOSPHATE 75MG CAPSULES (NDC: 47781-470-13); 10 CT. BLISTERS PACKS AND OSELTAMIVIR PHOSPHATE 30MG CAPSULES (NDC: 47781-468-13); 10 CT. BLISTERS PACKS.
Recompete context. This contract's current period of performance ends on
2027-06-29 (in 10 months). When a period of performance ends, the
agency typically either recompetes the work, extends the incumbent, or exercises a remaining option.
An end date is the earliest reliable public signal that a follow-on may be coming, which is why capture
teams track it. It is not a guarantee of a recompete. All figures are drawn from
USAspending.gov (U.S. Treasury) and are public domain.
Other Department of Health and Human Services contracts on the cliff
| Incumbent | Ceiling value | Ends | Expiry |
|---|---|---|---|
| NOVITAS SOLUTIONS, INC. | $921,080,482 | 2026-08-31 | expiring now |
| VERIZON BUSINESS NETWORK SERVICES LLC | $406,353,536 | 2026-08-31 | expiring now |
| LEIDOS BIOMEDICAL RESEARCH INC | $371,787,375 | 2026-08-30 | expiring now |
| LEIDOS, INC. | $152,046,866 | 2026-08-31 | expiring now |
| LEIDOS BIOMEDICAL RESEARCH INC | $87,806,507 | 2026-08-30 | expiring now |
| LEIDOS BIOMEDICAL RESEARCH INC | $80,917,684 | 2026-08-31 | expiring now |